FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gunnar Birgegård

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

Sweden

Procedures

Bloodletting

Concepts & Ideas

Physiology

Erythropoiesis

Co-author Network

Publications

TOP 3
Maria Lönnberg; Mats Garle; Lina Lönnberg; Gunnar Birgegård
Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis.
Gunnar Birgegård
["The phone trap", cause of many cancer notices by telephone].
Carles Besses; Brihad Abhyankar; Ruth Coll; Martin Griesshammer; Luigi Gugliotta; Claire Harrison; Jean-Jacques Kiladjian; Jonathan Smith; Gunnar Birgegård
Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gunnar Birgegård (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maria Lönnberg; Mats Garle; Lina Lönnberg; Gunnar Birgegård
Patients with anaemia can shift from kidney to liver production of erythropoietin as shown by glycoform analysis.
Journal of pharmaceutical and biomedical analysis 2013;81-82():187-92.
2013: Gunnar Birgegård
["The phone trap", cause of many cancer notices by telephone].
Läkartidningen 2013;110(8):422-3.
2013: Carles Besses; Brihad Abhyankar; Ruth Coll; Martin Griesshammer; Luigi Gugliotta; Claire Harrison; Jean-Jacques Kiladjian; Jonathan Smith; Gunnar Birgegård
Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS study.
Leukemia research 2013;37(2):162-8.
2013: Jean-Jacques Kiladjian; Jonathan Smith; Carles Besses; Ruth Coll; Martin Griesshammer; Luigi Gugliotta; Claire Harrison; Gunnar Birgegård
Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS study.
Clinical drug investigation 2013;33(1):55-63.
2013: Elisabeth Ejerblad; Hans M Kvasnicka; Eva Löfvenberg; Berit Markevärn; Mats Merup; Lars Nilssson; Jan Palmblad; Jan Samuelsson; Jürgen Thiele; Björn Andreasson; Magnus Björkholm; Gunnar Birgegård
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up.
Hematology (Amsterdam, Netherlands) 2013;18(1):8-13.
2012: Anncarin Svanberg; Hans Broström; Kerstin Ohrn; Gunnar Birgegård
The effect of cryotherapy on oral mucosa: a study in healthy volunteers.
Medical oncology (Northwood, London, England) 2012;29(5):3587-91.
2012: Peter Johansson; Ruben Mesa; Jan Samuelsson; Robyn Scherber; Johanna Abelsson; Gunnar Birgegård; Björn Andréasson
Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms.
Leukemia & lymphoma 2012;53(3):441-4.
2012: J Abelsson; Björn Andréasson; Gunnar Birgegård; L Brinch; M Brune; Peter Johansson; M Kauppila; Stig Lenhoff; M Liljeholm; C Malm; Mats Merup; K Remes; L Vindelöv; O WeisBjerrum
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries.
Bone marrow transplantation 2012;47(3):380-6.
2012: Maria Lönnberg; Maria Andrén; Gunnar Birgegård; Malin Drevin; Mats Garle; Jan Carlsson
Rapid detection of erythropoiesis-stimulating agents in urine and serum.
Analytical biochemistry 2012;420(2):101-14.
2011: Herman Nilsson-Ehle; Anna Olsson; Jan Samuelsson; Mette Skov-Holm; Jonas Wallvik; Petar Antunovic; Jan Astermark; Gunnar Birgegård; Lena M Engström; Hege Garelius; Nina Gulbrandsen; Lars Kjeldsen; Lars Nilsson; Eva Hellström-Lindberg
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions.
European journal of haematology 2011;87(3):244-52.
2011: Matti Aapro; Yves Beguin; Gunnar Birgegård; Pere Gascón; Michael Hedenus; Anders Osterborg
Too-low iron doses and too many dropouts in negative iron trial?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):e525-6; author reply e527-8.
2011: Magnus Björkholm; Asa Rangert Derolf; Charlotta Ekstrand; Lynn R Goldin; Fredrik Granath; Malin Hultcrantz; Sigurdur Y Kristinsson; Olle Linder; Claes Malm; Berit Markevärn; Lars Nilsson; Jan Samuelsson; Björn Andreasson; Gunnar Birgegård; Ola Landgren
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2410-5.
2011: Tiziano Barbui; Giovanni Barosi; Gunnar Birgegård; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben A Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):761-70.
2010: Gunnar Birgegård; K Schneider; Jan Ulfberg
High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.
Vox sanguinis 2010;99(4):354-61.
2010: Anncarin Svanberg; Kerstin Ohrn; Gunnar Birgegård
Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial.
Journal of clinical nursing 2010;19(15-16):2146-51.
2010: Charles L Bennett; June M McKoy; Michael Henke; Samuel Michael Silver; Iain C MacDougall; Gunnar Birgegård; stefano luminari; Nicole Casadevall; Huub Schellekens; Oliver Sartor; Stephen Y Lai; James O Armitage
Reassessments of ESAs for cancer treatment in the US and Europe.
Oncology (Williston Park, N.Y.) 2010;24(3):260-8.
2010: Giovanni Barosi; Gunnar Birgegård; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Hasselbalch; Jean-Jacques Kiladijan; Eva Lengfelder; Ruben Mesa; Mary F Mc Mullin; Francesco Passamonti; John T Reilly; Alessandro M Vannucchi; Tiziano Barbui
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
British journal of haematology 2010;148(6):961-3.
2010: Magnus Tobiasson; Bassam Alyass; Susanne Söderlund; Gunnar Birgegård
High prevalence of restless legs syndrome among patients with polycytemia vera treated with venesectio.
Medical oncology (Northwood, London, England) 2010;27(1):105-7.
2009: Juergen Thiele; Hans Michael Kvasnicka; James W Vardiman; Attilio Orazi; Vito Franco; Heinz Gisslinger; Gunnar Birgegård; Martin Griesshammer; Ayalew Tefferi
Bone marrow fibrosis and diagnosis of essential thrombocythemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):e220-1; author reply e222-3.
2009: Gunnar Birgegård
New perspectives in managing myeloproliferative disorders: focus on the patient.
Hematological oncology 2009;27 Suppl 1():5-7.
2009: Giovanni Barosi; Gunnar Birgegård; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Jean-Jacques Kiladjian; Eva Lengfelder; Mary Frances McMullin; Francesco Passamonti; John T Reilly; Alessandro M Vannucchi; Tiziano Barbui
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.
Blood 2009;113(20):4829-33.
2009: Astrid Hoppe; Elisabeth Persson; Gunnar Birgegård
Medical interns' view of their undergraduate medical education in Uppsala: an alumnus study with clear attitude differences between women and men.
Medical teacher 2009;31(5):426-32.
2009: Gunnar Birgegård
Long-term management of thrombocytosis in essential thrombocythaemia.
Annals of hematology 2009;88(1):1-10.
2009: M Hedenus; Gunnar Birgegård
The role of iron supplementation during epoietin treatment for cancer-related anemia.
Medical oncology (Northwood, London, England) 2009;26(1):105-15.
2008: Gunnar Birgegård; Stellan Sandler; Johannes Bergsten; Olle Nilsson
[The new medical education in Uppsala. Case-based, integrated and with early patient contact].
Läkartidningen 2008;105(51-52):3724-8.
2008: Matti S Aapro; Gunnar Birgegård; Carsten Bokemeyer; Paul Cornes; Jan Foubert; Pere Gascon; John Glaspy; Eva Hellström-Lindberg; Hartmut Link; Heinz Ludwig; Anders Osterborg; Lazzaro Repetto; Pierre Soubeyran
Erythropoietins should be used according to guidelines.
The lancet oncology 2008;9(5):412-3.
2008: Gunnar Birgegård
Managing anemia in lymphoma and multiple myeloma.
Therapeutics and clinical risk management 2008;4(2):527-39.
2008: Astrid Hoppe; Elisabeth M Persson; Gunnar Birgegård
[A questionnaire about the view of graduates on undergraduate medical education. Obvious attitude differences between women and men].
Läkartidningen 2008;105(9):620-3.
2008: Kirsti Lonka; Parvaneh Sharafi; Klas Karlgren; Italo Masiello; Juha Nieminen; Gunnar Birgegård; Anna Josephson
MED NORD--A tool for measuring medical students' well-being and study orientations.
Medical teacher 2008;30(1):72-9.
2008: Gunnar Birgegård; Elisabeth Persson; Astrid Hoppe
Randomized comparison of student-activating and traditional lecture: no learning difference.
Medical teacher 2008;30(8):819.
2008: Jan Palmblad; Magnus Björkholm; Jack Kutti; Gerd Lärfars; Eva Löfvenberg; Berit Markevärn; Mats Merup; Nils Mauritzson; Jan Westin; Jan Samuelsson; Gunnar Birgegård
TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
International journal of medical sciences 2008;5(2):87-91.
2007: Camilla Fröjd; Claudia Lampic; Gunnel Larsson; Gunnar Birgegård; Louise von Essen
Patient attitudes, behaviours, and other factors considered by doctors when estimating cancer patients' anxiety and desire for information.
Scandinavian journal of caring sciences 2007;21(4):523-9.
2007: Gunnar Birgegård
Essential thrombocythaemia treatment options: addressing patient-specific needs.
European journal of haematology. Supplementum 2007;(68):27-31.
2007: Anncarin Svanberg; Gunnar Birgegård; Kerstin Ohrn
Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(10):1155-61.
2007: Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegård; Ruben A Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.
Blood 2007;110(4):1092-7.
2007: Michael Hedenus; Gunnar Birgegård; P Näsman; L Ahlberg; T Karlsson; B Lauri; J Lundin; Gerd Lärfars; Anders Osterborg
Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.
Leukemia 2007;21(4):627-32.
2007: Giovanni Barosi; C Besses; Gunnar Birgegård; Jean Briere; Francisco Cervantes; Guido Finazzi; Heinz Gisslinger; Martin Griesshammer; Luigi Gugliotta; C Harrison; Hans Carl Hasselbalch; Eva Lengfelder; John T Reilly; JJ Michiels; Tiziano Barbui
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.
Leukemia 2007;21(2):277-80.
2007: Gunnar Birgegård; Fredrik Dahl; Bengt Glimelius; Ulf Landegren
Evaluation of beta globin mRNA as an early marker of haemoglobin response to epoetin treatment.
Medical oncology (Northwood, London, England) 2007;24(3):318-22.
2007: Jane Ahlqvist Rastad; Maria Albertsson; Jonas Bergh; Gunnar Birgegård; Peter Johansson; Bertil Jonsson; Elisabeth Kjellen; Sven Påhlman; Björn Zackrisson; Anders Osterborg
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations.
Medical oncology (Northwood, London, England) 2007;24(3):267-72.
2007: Magnus Hultdin; Gunnel Sundström; Ake Wahlin; Berith Lundström; Jan Samuelsson; Gunnar Birgegård; Anna Engström-Laurent
Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
Medical oncology (Northwood, London, England) 2007;24(1):63-70.
2006: Gunnar Birgegård; Pere Gascón; Heinz Ludwig
Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.
European journal of haematology 2006;77(5):378-86.
2006: Mats Merup; Vladimir Lazarevic; Hareth Nahi; Björn Andreasson; Claes Malm; Lars Nilsson; Mats Brune; Katarina LeBlanc; Jack Kutti; Gunnar Birgegård
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
British journal of haematology 2006;135(3):367-73.
2006: Jan Samuelsson; Manuel Mutschler; Gunnar Birgegård; Poul Gram-Hansen; Magnus Björkholm; Heike L Pahl
Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.
Haematologica 2006;91(9):1281-2.
2006: Jan Samuelsson; Hans Carl Hasselbalch; Oystein Bruserud; Snezana Temerinac; Yvonne Brandberg; Mats Merup; Olle Linder; Magnus Bjorkholm; Heike L Pahl; Gunnar Birgegård
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
Cancer 2006;106(11):2397-405.
2006: Gunnar Birgegård
Anagrelide treatment in myeloproliferative disorders.
Seminars in thrombosis and hemostasis 2006;32(3):260-6.
2006: Peter Barrett-Lee; Heinz Ludwig; Gunnar Birgegård; Carsten Bokemeyer; Pere Gascón; Paris A Kosmidis; Maciej Krzakowski; J W R Nortier; Gail Kongable; Maurice Schneider; Dirk Schrijvers; Simon van Belle
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.
Oncology 2006;70(1):34-48.
2005: Gunnar Birgegård; Carsten Bokemeyer
New guidelines on anaemia management in patients with cancer: How do these affect clinical practice?
Oncology 2005;69 Suppl 2():17-21.
2005: Gunnar Birgegård; Matti S Aapro; Carsten Bokemeyer; Mario Dicato; Peter Drings; Javier Hornedo; Maciej Krzakowski; Heinz Ludwig; Sergio Pecorelli; Hans Schmoll; Maurice Schneider; Dirk Schrijvers; Daniel Shasha; Simon van Belle
Cancer-related anemia: pathogenesis, prevalence and treatment.
Oncology 2005;68 Suppl 1():3-11.
2004: Heinz Ludwig; Simon van Belle; Peter Barrett-Lee; Gunnar Birgegård; Carsten Bokemeyer; Pere Gascón; Paris A Kosmidis; Maciej Krzakowski; J W R Nortier; Patrizia Olmi; Maurice Schneider; Dirk Schrijvers
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2293-306.
2004: Gunnar Birgegård; Magnus Björkholm; Jack Kutti; Gerd Lärfars; Eva Löfvenberg; Berit Markevärn; Mats Merup; Jan Palmblad; Nils Mauritzson; Jan Westin; Jan Samuelsson
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
Haematologica 2004;89(5):520-7.
2003: Anette Hagberg; Gisela Barbany; Ulf Landegren; Gunnar Birgegård
Beta-globin mRNA increases rapidly during erythropoietin treatment.
Scandinavian journal of clinical and laboratory investigation 2003;63(3):239-45.
2002: Gunnar Birgegård
[You can inform her, right... Breaking the news about cancer requires well-considered structure and empathy].
Läkartidningen 2002;99(13):1468-71.
2001: Gunnar Birgegård; Bo Sandhagen
Erythropoetin treatment can increase 2,3-diphosphoglycerate levels in red blood cells.
Scandinavian journal of clinical and laboratory investigation 2001;61(5):337-40.
1999: Björn Andréasson; E Wahlström; S Jacobsson; Magnus Björkholm; Jan Samuelsson; Gunnar Birgegård; Hans Wadenvik; Jack Kutti
The measurement of venous haematocrit in patients with polycythaemia vera.
Journal of internal medicine 1999;246(3):293-7.
1998: Gunnar Birgegård; U Lindquist
Change in student attitudes to medical school after the introduction of problem-based learning in spite of low ratings.
Medical education 1998;32(1):46-9.
1997: J Milbrink; Gunnar Birgegård; A Danersund; C Helmers; L Nordström; Bo Sandhagen
Preoperative autologous donation of 6 units of blood during rh-EPO treatment.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 1997;44(12):1315-8.
1997: H Hagberg; O Lannemyr; S Acosta; Gunnar Birgegård; H Hagberg
Successful treatment of syndrome of inappropriate antidiuretic secretion (SIADH) in 2 patients with CNS involvement of chronic lymphocytic leukaemia.
European journal of haematology 1997;58(3):207-8.
1997: Soheir Beshara; Gunnar Birgegård; J Goch; J Wahlberg; Björn Wikström; Bo G Danielson
Assessment of erythropoiesis following renal transplantation.
European journal of haematology 1997;58(3):167-73.
1996: J Goch; Gunnar Birgegård; Björn Wikström; U Backman; J Wadström; Bo G Danielson
Serum erythropoietin and erythropoiesis during six years after kidney transplantation.
Nephron 1996;74(4):687-93.
1996: J Goch; Gunnar Birgegård; Bo G Danielson; Björn Wikström
Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test.
Nephron 1996;73(3):403-6.
1995: Gunnar Birgegård; U Lindqvist; S Ljunghall
[Personal instruction in a new model of education].
Läkartidningen 1995;92(45):4196-8, 4200.
1995: J Goch; Gunnar Birgegård; Bo G Danielson; Björn Wikström
Treatment of erythropoietin-resistant anaemia with desferrioxamine in patients on haemofiltration.
European journal of haematology 1995;55(2):73-7.
1995: B Glimelius; Gunnar Birgegård; Katarina Hoffman; G Kvale; Per-Olow Sjödén
Information to and communication with cancer patients: improvements and psychosocial correlates in a comprehensive care program for patients and their relatives.
Patient education and counseling 1995;25(2):171-82.
1995: Gunnar Birgegård; U Eriksson
[The Uppsala profile in medical education. A combination of knowledge of human nature and biology].
Läkartidningen 1995;92(4):299-302.
1993: Eva Hellström-Lindberg; Gunnar Birgegård; M Carlsson; Jan Carneskog; Inger Marie S Dahl; I Dybedal; Gunnar Grimfors; K Merk; Jon Magnus Tangen; I Winqvist
A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes.
Leukemia & lymphoma 1993;11(3-4):221-8.
1992: Gunnar Birgegård; L Wide
Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.
British journal of haematology 1992;81(4):603-6.
1992: B Gudbjörnsson; Roger Hällgren; L Wide; Gunnar Birgegård
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin.
Annals of the rheumatic diseases 1992;51(6):747-52.
1992: J Goch; Gunnar Birgegård; Björn Wikström; G Tufveson; Bo G Danielson
Serum erythropoietin levels in the immediate kidney-posttransplant period.
Nephron 1992;60(1):30-4.
1992: Bengt Glimelius; Gunnar Birgegård; Katarina Hoffman; C Hägnebo; G Högman; G Kvale; Karin Nordin; E Nõu; C Persson; Per-Olow Sjödén
Improved care of patients with small cell lung cancer. Nutritional and quality of life aspects.
Acta oncologica (Stockholm, Sweden) 1992;31(8):823-31.
1991: E Haldén; Gunnar Birgegård; O Duvernoy; A Henze
[Erythropoietin made surgery for aortic coarctation possible in a Jehovah's witness patient].
Läkartidningen 1991;88(49):4245-6.
1991: E Hellström; Gunnar Birgegård; D Lockner; C Helmers; Ake Ost; L Wide
Treatment of myelodysplastic syndromes with recombinant human erythropoietin.
European journal of haematology 1991;47(5):355-60.
1991: P B Andersen; Gunnar Birgegård; R Nyman; A Hemmingsson
Magnetic resonance imaging in idiopathic hemochromatosis.
European journal of haematology 1991;47(3):174-8.
1991: Gunnar Birgegård; A Danersund; C Högman; J Milbrink; L Wide
Physiological response to phlebotomies for autologous transfusion at elective hip-joint surgery.
European journal of haematology 1991;46(3):136-9.
1991: Gunnar Birgegård; B Gudbjrönsson; R Hällgren; L Wide
Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.
Contributions to nephrology 1991;88():295-303; discussion 304-5.
1990: Bengt Glimelius; Gunnar Birgegård; E Nõu; Per-Olow Sjödén; H Ahlbom; I Engblom; M Hursti; Katarina Hoffman; G Högman; B Johansson
[A project in Uppsala. Improved care of cancer patients under treatment with antineoplastic agents].
Läkartidningen 1990;87(30-31):2428-31.
1989: B Berglund; Gunnar Birgegård; L Wide; P Pihlstedt
Effects of blood transfusions on some hematological variables in endurance athletes.
Medicine and science in sports and exercise 1989;21(6):637-42.
1989: Gunnar Birgegård; L Wide; Bengt Simonsson
Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation.
British journal of haematology 1989;72(3):462-6.
1989: L Wide; C Bengtsson; Gunnar Birgegård
Circadian rhythm of erythropoietin in human serum.
British journal of haematology 1989;72(1):85-90.
1989: Gunnar Birgegård
Erythropoiesis and inflammation.
Contributions to nephrology 1989;76():330-9; discussion 339-41.
1988: B Berglund; Gunnar Birgegård; P Hemmingsson
Serum erythropoietin in cross-country skiers.
Medicine and science in sports and exercise 1988;20(2):208-9.
1987: Gunnar Birgegård; C H de Verdier; C Högman
A comparison between concentrations of free erythrocyte protoporphyrin and serum ferritin during development of iron deficiency by phlebotomy in polycythaemia vera patients.
Scandinavian journal of clinical and laboratory investigation 1987;47(6):593-7.
1987: B Berglund; P Hemmingsson; Gunnar Birgegård
Detection of autologous blood transfusions in cross-country skiers.
International journal of sports medicine 1987;8(2):66-70.
1987: Gunnar Birgegård; R Hällgren; J Caro
Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment.
British journal of haematology 1987;65(4):479-83.
1986: S Ahlstedt; Gunnar Birgegård; I Hammarström; M B Into-Malmberg; M Jontell; J Denburg; E Akerblom
Stimulation of maturation of large immature histamine-containing basophilic cells from human peripheral blood, cord blood and bone marrow.
Immunology 1986;59(4):549-55.
1986: K Forsbeck; J Ericsson; Gunnar Birgegård; M Malmgren; K Nilsson
Subcellular characterization of the transferrin-transferrin receptor and iron accumulating system of established human erythroid and monoblastoid tumour cell lines.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology 1986;94(4):245-52.
1986: J Liljestrand; S Bergström; Gunnar Birgegård
Anaemia of pregnancy in Mozambique.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1986;80(2):249-55.
1984: Gunnar Birgegård; J Caro
Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages.
Scandinavian journal of haematology 1984;33(1):43-8.
1984: Gunnar Birgegård; M Carlsson; Bo Sandhagen; F Mannting
Does iron deficiency in treated polycythemia vera affect whole blood viscosity?
Acta medica Scandinavica 1984;216(2):165-9.
1983: R Hast; T Miale; J Westin; Gunnar Birgegård; E Möller; P Reizenstein; A C Teger-Nilsson; L Wetterberg
Hereditary ring sideroblastic anaemia and Christmas disease in a Swedish family.
Scandinavian journal of haematology 1983;30(5):444-50.
1982: J Caro; A J Erslev; R Silver; O Miller; Gunnar Birgegård
Erythropoietin production in response to anemia or hypoxia in the newborn rat.
Blood 1982;60(4):984-8.
1982: Gunnar Birgegård; O Miller; J Caro; A Erslev
Serum erythropoietin levels by radioimmunoassay in polycythaemia.
Scandinavian journal of haematology 1982;29(2):161-7.
1981: J Caro; R Silver; A J Erslev; O P Miller; Gunnar Birgegård
Erythropoietin production in fasted rats. Effects of thyroid hormones and glucose supplementation.
The Journal of laboratory and clinical medicine 1981;98(6):860-8.
1981: M Gebre-Medhin; Gunnar Birgegård
Serum ferritin in Ethiopian mothers and their newborn infants. Relation to iron intake and socio-economic conditions.
Scandinavian journal of haematology 1981;27(4):247-52.
1981: Gunnar Birgegård; P Nilsson; L Wide
Regulation of iron therapy by S-ferritin estimations in patients on chronic hemodialysis.
Scandinavian journal of urology and nephrology 1981;15(1):69-72.
1981: L Lundin; R Hällgren; Gunnar Birgegård; L Wide
Serum ferritin in alcoholics and the relation to liver damage, iron state and erythropoietic activity.
Acta medica Scandinavica 1981;209(4):327-31.
1980: Gunnar Birgegård
The source of serum ferritin during infection. Studies with concanavalin A--Sepharose absorption.
Clinical science (London, England : 1979) 1980;59(5):385-7.
1980: R Hällgren; A Terent; L Wide; K Bergström; Gunnar Birgegård
Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding.
Acta neurologica Scandinavica 1980;61(6):384-92.
1980: Gunnar Birgegård
Serum ferritin: physiological and methodological studies.
Clinica chimica acta; international journal of clinical chemistry 1980;103(3):277-85.
1980: Gunnar Birgegård; C Högman; A Johansson; A Killander; B Simonsson; L Wide
Serum ferritin in the regulation of iron therapy in blood donors.
Vox sanguinis 1980;38(1):29-35.
1980: A J Erslev; J Caro; Gunnar Birgegård; R Silver; O Miller
The biogenesis of erythropoietin.
Experimental hematology 1980;8 Suppl 8():1-13.
1979: Gunnar Birgegård; R Hällgren; P Venge; L Wide
Serum ferritin during inflammation. A study on myocardial infarction.
Acta medica Scandinavica 1979;206(5):361-6.
1979: Gunnar Birgegård; R Hällgren; A Killander; P Venge; L Wide
Serum ferritin during infection. A longitudinal study in renal transplant patients.
Acta medica Scandinavica 1979;205(7):641-5.
1978: Gunnar Birgegård; R Hällgren; A Killander; A Strömberg; P Venge; L Wide
Serum ferritin during infection. A longitudinal study.
Scandinavian journal of haematology 1978;21(4):333-40.
1978: Gunnar Birgegård; C Högman; A Killander; L Wide
Serum ferritin levels in male blood donors: relation to number of phlebotomies and iron supplementation.
Vox sanguinis 1978;34(2):65-70.
1977: Gunnar Birgegård; C Högman; A Killander; H Levander; B Simonsson; L Wide
Serum ferritin and erythrocyte 2,3-DPG during quantitated phlebotomy and iron treatment.
Scandinavian journal of haematology 1977;19(4):327-33.
1977: Leif Wide; Gunnar Birgegård
A solid phase radioimmunoassay method for ferritin in serum using (125)I-labelled ferritin.
Upsala journal of medical sciences 1977;82(1):15-9.
1977: B Simonsson; Gunnar Birgegård; A Killander; H Levander
Ferastral treatment of three healthy phlebotomized males.
Scandinavian journal of haematology. Supplementum 1977;32():239-44.
1974: Gunnar Birgegård; K E Fjellström; R Forrest; P Sjöström; C E Westerberg
[A case of chyluria].
Läkartidningen 1974;71(38):3490.